Alterations in PTEN were frequently observed in lung cancer, both in adenocarcinoma (ADC) and squamous cell carcinoma (SCC), ranging between 15 and 38%, respectively (Fig. 1A). This evidence concerns the gene PTEN and squamous cell carcinoma.